Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Body Height × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Inflammation 1 Feeding Behavior 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1 Breast Neoplasms 1 Breast Diseases 1

Interventions

Megestrol Acetate 9 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Infliximab 2 Ibuprofen 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 Vitamin D 1 Ultrasonography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03172403 2022-08-25

MYOCAC

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Gastrointestinal

Cachexia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡